FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Meitheal Recalls Cisatracurium Besylate Injection

[ Price : $8.95]

FDA says Meitheal Pharmaceuticals is recalling one lot of cisatracurium besylate injection in which some cartons were mislabeled.

Organicell Regenerative Medicine IND for COPD Therapy

[ Price : $8.95]

FDA clears an Organicell Regenerative Medicine IND for Zofin and its use in treating patients diagnosed with chronic obstructive p...

Noorchashm Warns of Covid Vaccine Immunological Danger

[ Price : $8.95]

Cardiac surgeon Hooman Noorchashm asks FDA, Pfizer, and Moderna to consider recommending that vaccines be delayed for those who ar...

FDA Drug Inspections Resuming in China and India

[ Price : $8.95]

FDA says it is resuming prioritized drug inspections by investigator staff in China and India.

Bio-Thera BLA for Avastin Biosimilar

[ Price : $8.95]

FDA accepts for review a Bio-Thera Solutions BLA for BAT1706, a proposed biosimilar to Genentechs Avastin (bevacizumab).

FDA Continuing Rifampin/Rifapentine Products Analysis

[ Price : $8.95]

FDA distributes its laboratory analyses of MNP in rifampin and CPNP in rifapentine.

FDA Updates Pandemic Coagulation System Guidance

[ Price : $8.95]

FDA publishes an updated pandemic guidance on coagulation systems to measure whole blood viscoelastic properties.

The Body Building Selling Unapproved Cellular Products: FDA

[ Price : $8.95]

FDA notifies The Body Building that it is marketing unapproved cellular products intended to treat several diseases and conditions...

KemPharm Plans Drug Trial for Stimulant Use Disorder

[ Price : $8.95]

FDA permits KemPharm to proceed under an IND with its planned clinical investigation of KP879 and its use in treating stimulant us...

PharmaCyte Starts CypCaps Studies Sought by FDA

[ Price : $8.95]

PharmaCyte says it has started additional DNA sequencing studies sought by FDA for the companys CypCaps pancreatic cancer product....